Group I (n = 20) | Group II (n = 20) | Group IIIa (n = 20) | Group IV (n = 20) | Test of sig. | p | |||||
---|---|---|---|---|---|---|---|---|---|---|
No. | % | No. | % | No. | % | No. | % | |||
Gender | ||||||||||
Male | 8 | 40.0 | 9 | 45.0 | 11 | 55.0 | 9 | 45.0 | χ2 = 0.955 | 0.812 |
Female | 12 | 60.0 | 11 | 55.0 | 9 | 45.0 | 11 | 55.0 | ||
Age (years) | ||||||||||
Min.–max. | 39.0–49.0 | 41.0–49.0 | 39.0–56.0 | 37.0–54.0 | F = 1.605 | 0.195 | ||||
Mean ± SD. | 44.65 ± 3.15 | 45.70 ± 2.05 | 45.90 ± 4.79 | 43.55 ± 4.62 | ||||||
Median (IQR) | 45 (42.5–47.0) | 45.5 (44–47.5) | 46.0 (41.5–49.5) | 44.0 (39.5–46.5) | ||||||
Hemoglobin | ||||||||||
Min.–Max. | 10.0–11.50 | 10.0–11.30 | 9.0–11.50 | 11.50–14.30 | F = 68.661* | < 0.001* | ||||
Mean ± SD. | 10.91 ± 0.45 | 10.75 ± 0.39 | 10.50 ± 0.59 | 12.86 ± 0.81 | ||||||
Median (IQR) | 10.90 (10.70–11.30) | 10.80 (10.55–11.0) | 10.70 (10.05–10.95) | 13.0 (12.0–13.35) | ||||||
p0 | < 0.001* | < 0.001* | < 0.001* | |||||||
Sig.bet.Grps | p1 = 0.836, p2 = 0.127, p3 = 0.515 | |||||||||
WBC(×103) | ||||||||||
Min.–max. | 4.0–9.0 | 3.0–8.30 | 2.70–8.90 | 5.0–8.0 | F = 2.841* | 0.043* | ||||
Mean ± SD. | 5.85 ± 1.38 | 5.17 ± 1.46 | 5.21 ± 1.73 | 6.26 ± 0.93 | ||||||
Median (IQR) | 5.75 (4.75–7.0) | 5.05 (4.0–6.30) | 5.15 (3.70–6.40) | 6.05 (5.55–7.0) | ||||||
p0 | 0.793 | 0.047* | 0.091 | |||||||
Sig.bet.Grps | p1 = 0.418, p2 = 0.472, p3 = 1.000 | |||||||||
Platelets (× 103) | ||||||||||
Min.–max. | 149.0–190.0 | 130.0–191.0 | 51.0–168.0 | 210.0–389.0 | F = 80.751* | < 0.001* | ||||
Mean ± SD. | 168.95 ± 13.40 | 157.70 ± 17.68 | 107.60 ± 37.99 | 272.80 ± 53.20 | ||||||
Median (IQR) | 168.0 (158.50–178.0) | 151.50 (145.0–172.50) | 104.0 (77.0–140.0) | 268.50 (224.5–309.5) | ||||||
p0 | < 0.001* | < 0.001* | < 0.001* | |||||||
Sig.bet.Grps | p1 = 0.732, p2 < 0.001*, p3 < 0.001* | |||||||||
Total bilirubin | ||||||||||
Min.–max. | 0.20–1.0 | 0.20–1.0 | 0.60–6.20 | 0.20–0.90 | H = 29.522* | < 0.001* | ||||
Mean ± SD. | 0.66 ± 0.27 | 0.73 ± 0.28 | 2.74 ± 2.03 | 0.59 ± 0.22 | ||||||
Median (IQR) | 0.73 (0.45–0.90) | 0.80 (0.45–1.0) | 2.05 (0.95–4.60) | 0.60 (0.45–0.75) | ||||||
p0 | 0.343 | 0.074 | < 0.001* | |||||||
Sig.bet.Grps | p1 = 0.404, p2 < 0.001*, p3 = 0.001* | |||||||||
Direct bilirubin | ||||||||||
Min.–max. | 0.10–0.80 | 0.10–0.80 | 0.40–5.30 | 0.10–0.70 | H = 29.094* | < 0.001* | ||||
Mean ± SD. | 0.46 ± 0.23 | 0.51 ± 0.22 | 2.16 ± 1.68 | 0.40 ± 0.19 | ||||||
Median (IQR) | 0.50 (0.25–0.70) | 0.53 (0.30–0.70) | 1.70 (0.70–3.60) | 0.35 (0.25–0.60) | ||||||
p0 | 0.415 | 0.145 | < 0.001* | |||||||
Sig.bet.Grps | p1 = 0.520, p2 < 0.001*, p3 = 0.001* | |||||||||
Albumin | ||||||||||
Min.–max. | 3.20–4.60 | 3.0–4.20 | 2.30–3.30 | 3.90–4.50 | F = 41.041* | < 0.001* | ||||
Mean ± SD. | 3.92 ± 0.48 | 3.62 ± 0.40 | 2.99 ± 0.28 | 4.15 ± 0.16 | ||||||
Median (IQR) | 4.0 (3.35–4.30) | 3.60 (3.25–4.0) | 3.05 (2.90–3.15) | 4.15 (4.0–4.30) | ||||||
p0 | 0.174 | < 0.001* | < 0.001* | |||||||
Sig.bet.Grps | p1 = 0.042*, p2 < 0.001*, p3 < 0.001* | |||||||||
ALT | ||||||||||
Min.–max. | 10.0–99.0 | 13.0–81.0 | 20.0–120.0 | 12.0–28.0 | H = 31.305* | < 0.001* | ||||
Mean ± SD. | 38.85 ± 25.97 | 36.25 ± 18.08 | 57.80 ± 30.38 | 19.90 ± 4.62 | ||||||
Median (IQR) | 29.50 (21.0–52.0) | 31.0 (24.50–40.50) | 47.0 (31.0–83.0) | 19.50 (17.0–22.50) | ||||||
p0 | 0.002* | 0.001* | < 0.001* | |||||||
Sig.bet.Grps | p1 = 0.716, p2 = 0.014*, p3 = 0.037* | |||||||||
AST | ||||||||||
Min.–max. | 42.0–132.0 | 50.0–121.0 | 33.0–117.0 | 7.0–24.0 | F = 48.157* | < 0.001* | ||||
Mean ± SD. | 75.45 ± 25.18 | 71.65 ± 17.95 | 72.90 ± 23.13 | 13.10 ± 4.45 | ||||||
Median (IQR) | 74.50 (53.5–93.5) | 71.0 (55.50–80.0) | 68.50 (58.0–89.5) | 12.0 10.0–15.50) | ||||||
p0 | < 0.001* | < 0.001* | < 0.001* | |||||||
Sig.bet.Grps | p1 = 0.926, p2 = 0.976, p3 = 0.997 | |||||||||
ALP | ||||||||||
Min.–max. | 50.0–135.0 | 67.0–170.0 | 59.0–251.0 | 50.0–111.0 | F = 13.208* | < 0.001* | ||||
INR | ||||||||||
Min.–max. | 1.0–1.32 | 1.10–1.50 | 1.40–2.10 | 0.90–1.20 | H = 61.021* | < 0.001* | ||||
Mean ± SD. | 1.13 ± 0.11 | 1.29 ± 0.11 | 1.69 ± 0.20 | 1.05 ± 0.08 | ||||||
Median (IQR) | 1.10 (1.0–1.22) | 1.30 (1.20–1.38) | 1.61 (1.55–1.80) | 1.0 (1.0–1.10) | ||||||
p0 | 0.103 | < 0.001* | < 0.001* | |||||||
Sig.bet.Grps | p1 = 0.015*, p2 < 0.001*, p3 = 0.001* | |||||||||
Prothrombin activity | ||||||||||
Min.–max. | 60.0–100.0 | 50.0–92.0 | 27.0–56.0 | 79.0–110.0 | H = 60.472* | < 0.001* | ||||
Mean ± SD. | 83.65 ± 14.72 | 65.80 ± 11.17 | 43.80 ± 8.30 | 94.30 ± 8.41 | ||||||
Median (IQR) | 90.0 (66.50–96.0) | 63.0 (58.50–74.0) | 45.50 (40.0–51.0) | 98.50 (87.5–100.0) | ||||||
p0 | 0.122 | < 0.001* | < 0.001* | |||||||
Sig.bet.Grps | p1 = 0.010*, p2 < 0.001*, p3 = 0.002* | |||||||||
Ascites | χ2 = 80.984* | < 0.001* | ||||||||
No | 14 | 10 | 0 | 20 | ||||||
Mild | 6 | 9 | 0 | 0 | ||||||
Moderate | 0 | 1 | 13 | 0 | ||||||
Massive | 0 | 0 | 7 | 0 | ||||||
Child Pugh classification | ||||||||||
A | 14 | 10 | 0 | NA | χ2 = 32.269* | MCp < 0.001* | ||||
B | 6 | 10 | 10 | |||||||
C | 0 | 0 | 10 | |||||||
Child Pugh score | ||||||||||
Min.–max. | 5.0–7.0 | 5.0–8.0 | 7.0–13.0 | NA | H = 31.398* | < 0.001* | ||||
Mean ± SD. | 5.70 ± 0.92 | 6.10 ± 1.17 | 9.55 ± 2.39 | |||||||
Median (IQR) | 5.0 (5.0–7.0) | 6.0 (5.0–7.0) | 9.50 (7.0–12.0) | |||||||
Sig.bet.Grps | p1 = 0.372, p2 < 0.001*, p3 < 0.001* |